药学与临床研究
藥學與臨床研究
약학여림상연구
PHARMACEUTICAL AND CLINICAL RESEARCH
2015年
3期
256-258
,共3页
郑娣%刘宇婧%张自强%钱伟刚%王柏
鄭娣%劉宇婧%張自彊%錢偉剛%王柏
정제%류우청%장자강%전위강%왕백
枸橼酸钾%缓释片%HPLC法%累积释放度
枸櫞痠鉀%緩釋片%HPLC法%纍積釋放度
구연산갑%완석편%HPLC법%루적석방도
Potassium Citrate%Sustained-release tablet%HPLC%Release profile
目的:制备枸橼酸钾缓释片并对其体外释放度进行研究。方法:采用正交设计法对枸橼酸钾缓释片处方进行优化,并采用相似因子对其体外释放行为进行评价;以高效液相色谱法检测枸橼酸钾缓释片的释放度。结果:正交设计结果表明,硬脂酸对枸橼酸钾的释放影响较为明显,通过Higuchi方程及Peppas方程拟合,确定枸橼酸钾缓释片的释药机制为扩散与溶蚀双重作用。结论:应用硬脂酸为骨架材料即可制备具有理想释药行为的枸橼酸钾缓释片,其释放度符合《中华人民共和国药典》2010年版标准且与参比缓释片(UROCIT-K)相似。
目的:製備枸櫞痠鉀緩釋片併對其體外釋放度進行研究。方法:採用正交設計法對枸櫞痠鉀緩釋片處方進行優化,併採用相似因子對其體外釋放行為進行評價;以高效液相色譜法檢測枸櫞痠鉀緩釋片的釋放度。結果:正交設計結果錶明,硬脂痠對枸櫞痠鉀的釋放影響較為明顯,通過Higuchi方程及Peppas方程擬閤,確定枸櫞痠鉀緩釋片的釋藥機製為擴散與溶蝕雙重作用。結論:應用硬脂痠為骨架材料即可製備具有理想釋藥行為的枸櫞痠鉀緩釋片,其釋放度符閤《中華人民共和國藥典》2010年版標準且與參比緩釋片(UROCIT-K)相似。
목적:제비구연산갑완석편병대기체외석방도진행연구。방법:채용정교설계법대구연산갑완석편처방진행우화,병채용상사인자대기체외석방행위진행평개;이고효액상색보법검측구연산갑완석편적석방도。결과:정교설계결과표명,경지산대구연산갑적석방영향교위명현,통과Higuchi방정급Peppas방정의합,학정구연산갑완석편적석약궤제위확산여용식쌍중작용。결론:응용경지산위골가재료즉가제비구유이상석약행위적구연산갑완석편,기석방도부합《중화인민공화국약전》2010년판표준차여삼비완석편(UROCIT-K)상사。
Objective: To prepare the potassium citrate sustained-release tablets and to investigate the release profile in vitro of the sustained-release tablets. Methods: HPLC was used as the analytical method, an orthogonal design method was used to optimize the formulation and a similarity factor method was used to evaluate the in vitro release behavior. Results: Stearic acid affected the release more obviously. Determined by Higuchi equation and Peppas equation fitting, the release of potassium citrate sustained-release tablets included dual mechanisms of diffusion and erosion. Conclusion: Applying stearic acid as the backbone, potassium citrate extended release tablets have the desired release behavior, in line with the release standard of "Chinese Pharmacopoeia" 2010 version, and is similar to the reference sustained-release tablets (UROCIT-K).